Literature DB >> 7466608

Newer prosthetic material compared with autogenous saphenous vein for occlusive arterial disease of the lower extremity.

J J Cranley, C D Hafner.   

Abstract

This article reports our experience with 101 polytetrafluoreoethylene and 102 umbilical vein grafts inserted into the femoropopliteal and femorocrural arteries of 98 and 97 patients, respectively, during the last 5 years. These grafted extremities are compared to 416 saphenous vein grafts placed in similar arteries of 383 patients during the past 18 years. The operations were performed by seven surgeons associated in private practice. During this period of time, all records were collated by our research associate, R. M. Preuninger, Ph.D., and the life-table analyses of the data were computed by S. Mehta of the Gore-Tex Company, using the method of Peto et al.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7466608

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

Review 1.  Factors contributing to success and failure of femorotibial bypass grafts.

Authors:  D F Courtney; W R Flinn; W J McCarthy; J S Yao; J J Bergan
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

2.  Use of an endothelial monolayer on a vascular graft prior to implantation. Temporal dynamics and compatibility with the operating room.

Authors:  B E Jarrell; S K Williams; L Solomon; L Speicher; E Koolpe; J Radomski; R A Carabasi; D Greener; F E Rosato
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

3.  The Dardik biograft in reconstructive arterial surgery: report on a five-year experience in 94 cases.

Authors:  D Raithel; H Schweiger
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

4.  The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up.

Authors:  S A Hirsch; F Jarrett
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.